On November 20, 2023, Altimmune Inc (NASDAQ: ALT) opened at $2.42, higher 7.79% from the last session. During the day, the shares moved up to $2.66 and dropped to $2.41 before settling in for the closing price of $2.44. Price fluctuations for ALT have ranged from $2.09 to $17.17 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -30.84%. Company’s average yearly earnings per share was noted 15.26% at the time writing. With a float of $53.19 million, this company’s outstanding shares have now reached $53.73 million.
The extent of productivity of a business whose workforce counts for 52 workers is very important to gauge.
Altimmune Inc (ALT) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Altimmune Inc is 1.01%, while institutional ownership is 56.75%. The most recent insider transaction that took place on Aug 15, was worth 862. In this transaction Director of this company bought 300 shares at a rate of $2.88, taking the stock ownership to the 29,785 shares. Before that another transaction happened on Mar 24, when Company’s Chief Financial Officer bought 10,000 for $4.31, making the entire transaction worth $43,140. This insider now owns 22,010 shares in total.
Altimmune Inc (ALT) Performance Highlights and Predictions
This company achieved a return on equity of -44.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of 260.57 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 15.26% per share during the next fiscal year.
Altimmune Inc (NASDAQ: ALT) Trading Performance Indicators
Check out the current performance indicators for Altimmune Inc (ALT). In the past quarter, the stock posted a quick ratio of 12.89. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 504.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.54, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.82 in one year’s time.
Technical Analysis of Altimmune Inc (ALT)
The latest stats from [Altimmune Inc, ALT] show that its last 5-days average volume of 1.16 million was inferior to 1.61 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 29.94%. Additionally, its Average True Range was 0.19.
During the past 100 days, Altimmune Inc’s (ALT) raw stochastic average was set at 35.06%, which indicates a significant decrease from 58.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 67.84% in the past 14 days, which was higher than the 59.24% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.55, while its 200-day Moving Average is $4.75. Now, the first resistance to watch is $2.72. This is followed by the second major resistance level at $2.82. The third major resistance level sits at $2.97. If the price goes on to break the first support level at $2.47, it is likely to go to the next support level at $2.32. Assuming the price breaks the second support level, the third support level stands at $2.22.
Altimmune Inc (NASDAQ: ALT) Key Stats
There are currently 53,729K shares outstanding in the company with a market cap of 141.31 million. Presently, the company’s annual sales total -70 K according to its annual income of -84,710 K. Last quarter, the company’s sales amounted to 360 K and its income totaled -20,670 K.